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Background: Migraine is a type of primary headache widely known for its impact on quality of life of patients.
Although the psychological aspects of the disease are receiving increasing attention in current research, some of
them, as alexithymia, are still seldom explored. This study aimed to provide evidence on the relationships between
markers of depression, anxiety, alexithymia, self-reflection, insight and quality of life in migraine.
Methods: Forty female outpatients from a Brazilian specialized headache hospital service and a paired control
group were compared.
Results: The results revealed that women with migraine had higher levels of depression, anxiety and alexithymia,
and lower levels of quality of life, self-reflection and insight, compared to controls. Quality of life in women with
migraine was predicted by levels of depression and one alexithymia factor (ability to express emotions and
fantasies). A binary regression analysis between clinical and control groups revealed the migraine group to
comprise individuals with high anxiety, low quality of life in the physical domain and the presence of a concrete
thinking style.
Conclusions: The results highlight the relevance of considering psychological variables in the routine healthcare
practices for migraine patients in general, while keeping steady attention to individual case features.
Keywords: Migraine, Alexithymia, Self-reflection, Insight, Quality of lifeBackground
Migraine is a type of primary headache afflicting in
average 11 percent of the global adult population and
approximately 15.2 percent of the Brazilian adult popu-
lation [1,2]. It is more prevalent in women than men,
a pattern that can also be observed in the Brazilian
population [2]. The relationship between migraine and
psychological factors such as cognitive processing
patterns (e.g., repetitive thinking and cognitive styles)
and personality traits has received increasing attention
within literature. Such research starts from the general
premise that the way individuals perceive and express
their ailment will have important effects in their rela-
tionship with treatment and in choosing strategies to
cope with the disorder.* Correspondence: rebecavieirapsico@gmail.com
Federal University of Rio Grande do Sul, Porto Alegre, Brazil
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in any medium, provided the original work is pOne of such relevant cognitive patterns is alexithymia,
which is more common in migraine sufferers comparing
to controls [3]. In a sample of medical students in Turkey,
migraine was associated with alexithymic personality traits
and comorbid psychiatric disorders [4]. There is also evi-
dence of a positive association between alexithymia, de-
pression and anxiety in migraine patients. Furthermore,
when compared with episodic migraine patients, chronic
migraine patients have significantly higher scores on
measures of depression, but not alexithymia and anxiety
[5]. In the same line, the relationship between alexithymia
and migraine was probed in a migraine "repeaters" sample
[6]. Repeaters show predominance of acute care for head-
ache with high use and overuse of symptomatic medica-
tion [7]. The authors concluded that alexithymia and
depressive mood associated with high disability may be
a typical psychosocial pattern of "repeater" migraine
patients.Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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when Peter Sifneos observed peculiar characteristics in
the emotional processing of psychosomatic patients [8].
Alexithymia is a multidimensional construct characterized
by reduced ability to identify and describe feelings, limited
capacity in engaging in fantasy or other imaginative
activities, and externally-oriented thinking. It may be
considered a deficit in one’s cognitive processing and
regulation of emotional states [9,10].
Apart from and psychosomatic disorders, alexithymia
has also been related to intensity of pain and functional
impairment in populations with medical conditions such
as neuromuscular disease, diabetes, hypertension and
asthma [11-17]. As it interferes in the adaptive regula-
tion of negative emotions resulting from stressing causes
or psychological conflicts, alexithymia tends also to be
stronger in individuals with chronic pain, such as
rheumatoid arthritis, fibromyalgia, temporomandibular
joint disorder and migraine [11,18]. However, there are
important individual differences in alexithymia as in the
intensity of pain, as much in the population in general
as in patients with chronic pain. A positive correlation
between alexithymia and the intensity of acute pain is
found in healthy individuals, although in patients with
chronic pain alexithymia it is not necessarily related to
the gravity of pain, or it has been only related to the
emotional, but not the sensorial dimension of pain [18].
The association between anxiety and alexithymia has
also been documented [19]. On the one hand, some
authors defend that alexithymia sufferers would be more
susceptible to anxiety [20]. On the other hand, there is
evidence suggesting that depression or anxiety might re-
sult in a reactive regression of the emotional develop-
ment and then provoke alexithymic characteristics [21].
Several studies have also supported the association be-
tween alexithymia and depression, even when alexithymia
measures appear to be relatively stable accross time when
compared to depression measures, suggesting they might
be different constructs [21-23]. However, mechanisms for
the association between alexithymia and depression are
not yet clear [24]. The investigation of psychiatric
comorbidities in migraine has been highlighted in some
studies not only because of its high impact on the
individual’s quality of life but also due to the association
between psychiatric comorbidities and suicide risk in
those patients [25-27]. Moreover, the correct assessment
of depression and anxiety in migraine patients seems to
play an important role for developing an adequate pre-
ventive treatment strategy, preventing the evolution of mi-
graine into a chronic illness [28].
There are empirical evidence in literature that alexithymia
might be associated with a worse quality of life. But there
is no consensus among authors if this association can
be observed only in some dimensions, such as thepsychological or the social quality of life, or if that
happens in all of its dimensions [29,30]. Besides, some
authors have found a negative correlation between satis-
faction with life and alexithymia, even by taking into
account confusion factors such as depression and
physical health perception, which shows a possibility
of low satisfaction with life being associated with dif-
ficulties in emotional processing, as is the case in
alexithymia sufferers [31].
Alexithymia has been associated with other constructs
related to the cognitive processing of psychic contents,
such as thoughts, feelings and behaviors. For instance,
self-reflection and insight were shown to be related to
different psychological variables such as alexithymia,
depression, anxiety and stress [32]. Self-reflection refers
to the activity of inspecting and evaluating personal
thoughts, sentiments and behaviors. Insight, on the
other hand, concerns the state of internal understanding
one has about one’s thoughts, sentiments and behaviors
[33]. The self-reflection dimension has been positively
correlated to anxiety and stress, but not to depression
and alexithymia [32]. However, the factor insight
was negatively correlated to depression, anxiety and
alexithymia.
The literature still has not offered evidences about the
impact of alexithymia on quality of life in migraine
sufferers in the Brazilian context. There are few studies
concerning possible correlations between alexithymia
and depression, anxiety and other construct indicators
involved in the self-monitoring of internal states such as
self-reflection and insight. This study aimed at investi-
gating the relations among the psychological factors
alexithymia, self-reflection, insight, depression, anxiety;
demographic variables; and aspects of the impacts of the
disorder on these patients’ lives, such as severity of
symptoms and quality of life in migraine sufferers as
compared to a group of matched controls.Methods
Participants
The clinical group was composed by 40 women with a
migraine without aura diagnosis, according to the Inter-
national Classification of Headache Disorders (2006) cri-
teria. Participants’ age ranged from 21 to 59 years old
(M = 43.58; DP = 10,71). The participants were selected
among the outpatients registered at the Headache Unit
of the Hospital de Clínicas de Porto Alegre (HCPA), a
reference public hospital in city of Porto Alegre, state
capital of Rio Grande do Sul, Brazil. The choice for
evaluating exclusively women in this study is due to the
profile of the population of outpatients attending the
Hospital’s Headache Unit, comprising approximately
95% female.
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general population, who were receiving clinical care for
other health issues than migraine, provided by general
practitioners at the local public health center. Controls
were paired with the clinical group by age, educational
level and income status. Controls age ranged from 24 to
59 years old (M = 42.15; DP = 10,53). Some participants
from the control group reported being in treatment for
hypertension (7 cases), diabetes (2 cases), asthma
(3 cases), labyrinthitis (1 case) and Ménièr’s Syndrome
(1 case). The implications of that profile will be
discussed in the last section of this article. At the public
health care center, participants in the control group were
questioned if they suffered of migraine or another type
of headache, being excluded from the group those who
presented any kind of headache, except infrequent epi-
sodic tensional headache. Participants in the clinical and
control groups who met criteria for psychotic disorder
or substance abuse, as screened by the instruments used
in the study, were excluded.
Instruments
CAGE
It is an instrument developed to track alcohol related
disorders [34]. It consists of four short questions about
alcohol ingestion followed by Yes or No answers. More
than one affirmative response means the participant has
alcohol related problems.
Self report questionnaire
SRQ is a psychiatric disorders screening questionnaire
formed by 24 questions subdivided in two sections: 20
questions aim at “neurotic” disorders detection and the
remaining four questions track “psychotic” disorders
[35]. The “neurotic” disorders correspond to mood, anx-
iety and somatoform disorders, assessed by the SCID-IV
-TR (Structured Clinical Interview for DSM-IV-TR) [36].
Brazilian version of the self-reflection and insight scale
The Self-Reflection and Insight Scale consists of a self-
applied questionnaire formed by 20 items participants
respond to a five-point Likert scale [32]. The results of
the Brazilian adaptation study revealed satisfactory in-
ternal consistency indexes, with a Cronbach’s alpha of
0.902 for the Self-reflection dimension, and 0.825 for
Insight [33].
Toronto alexithymia scale
It is a self-evaluation instrument formed by 26 items,
and originally idealized to measure alexithymia degrees
based on four factors [37]. The validation of the Brazil-
ian TAS version with a clinical sample of 294 general
hospital patients revealed a good internal consistency,
with a Cronbach’s alpha of 0.72 [38]. The authorperformed a factor analysis of the scale and suggested a
three factors model as more adequate for clinical
samples. Items in the first factor (ALEX1) were
associated with the ability to identify feelings and distin-
guish them from bodily sensations. Items in the second
factor (ALEX2) relate to a concrete thinking style. Items
in the third factor (ALEX3) concern the ability to ex-
press emotion and fantasy (daydreaming). With this re-
lease of three factors, the Brazilian version of TAS for
clinical population is reduced to 22 items. There are cur-
rently no established cutoff points for the Brazilian
population [38].
Beck anxiety inventory
It is a self-report scale that measures the intensity of
anxiety-related signals and symptoms [39]. The instru-
ment comprises 21 descriptive affirmatives of anxiety
symptoms to be evaluated by the individual in a four-
point scale that reflects the gravity of each symptom.
The total score is obtained by adding up the scores of
the individual items. The cutoff scores for the BAI are
0–10 (minimal), 11–19 (mild), 20–30 (moderate) and
31–63 (severe). Cronbach’s alpha for BAI in clinical
samples varies from 0.74 to 0.88.
Beck depression inventory
It is a self-report scale with 21 items, each one with four
alternatives, related to increasing degrees of depression
gravity with scores from 0 to 3 [39]. The total score is
the sum of the individual scores of the items. BDI cutoff
scores are 1–11 (minimal depression), 12–19 (mild de-
pression), 20–35 (moderate depression) and 36–63 (se-
vere depression). Cronbach’s alpha in clinical-medical
samples varies from 0.77 to 0.92.
WHOQOL-BREF
The short version of World Health Organization's Qual-
ity of Life (WHOQOL-100) assesses quality of life in the
physical (WHO1), psychological (WHO2), social
relations (WHO3) and environmental domains (WHO4)
[40]. The instrument has shown satisfactory results on
discriminant validity, criterion validity, concurrent valid-
ity, and test-retest and internal consistency reliability
both for the specific domains and the complete scale
(WHO).
Procedure
Participants of the clinical group were found through
the patients roll at the HCPA headache ambulatory be-
tween May and November, 2011. The instruments were
applied in one occasion, on the same day of patients’
routine doctor’s appointment. Data collection was previ-
ously scheduled with the patients by phone and done at
the Clinical Research Center. Participants in the control
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waited for their doctor’s appointment at the public
health care center of their community. With their ac-
ceptance and after checking exclusion criteria, they were
paired by age, educational level, and income to the
participants of the clinical group. All the participants
gave their informed consent prior to their inclusion in
the study. The study received the approval by the
Hospital's Institutional Review Board.Data analysis
The data matrix was inspected and the missing values
were substituted by the average value of the case in the
respective variable. Descriptive statistics were performed
for the sociodemographic data for the total participants,
as well as for the control and clinical groups in separate.
Inferential statistics were also run for groups and overall
sample (Chi-squared test, student’s t-test, Pearson cor-
relation, analysis of covariance, multiple regression ana-
lysis, binary logistic regression), using SPSS (Statistical
Package for Social Sciences), and adopting a 5% signifi-
cance level.Table 1 Sociodemographic characteristics of the sample
Variables Control group
Age: Mean (SD) 42,15 (10,53)
Range 24-59
Educational Elementary = 14 (42,
Level: f (%) High school = 11 (33
Professional = 3 (9,1)
College = 5 (15,2)
Outcome (in current minimum wages): f (%) Until 1 = 0 (0)
From 1 to 3 = 22 (66
From 3 to 5 = 10 (30
From 5 to 10 = 1 (3)
Marital status: f (%) Married = 14 (42,4)
Divorced =5 (15,2)
Single = 11 (33,3)









SD = standard deviation, f = frequency, % = percentage.Results
Sociodemographic characteristics of the sample are
shown at Table 1. Significant differences regarding those
features between the control and clinical groups were
not found. The same table features the values of dur-
ation of disease in months (DD), duration of treatment
in months (DT), pain frequency in the last three months
in days (PF) and an average grade attributed by the
participants to their pain in the last three months in a
scale ranging from 0–10 (PG) for the clinical group are
described. To evaluate the grade attributed to the pain
(PG) and the frequency of pain (FP) the authors used
two questions from the Migraine Disability assessment
Scale-MIDAS [41], a widely used measure of headache-
related disability in migraine. The questions were "On
how many days in the last 3 months did you have a
headache?" and "On a scale of 0 to 10, on average how
painful were these headaches? (where 0 = no pain at all
and 10 = pain as bad as it can be".
A comparison among the average levels of the
variables investigated in the present study is shown at
Table 2. Significant differences were observed in all
variables between the control and clinical groups. TheClinical group Total
43,58 (10,71) 42,93 (10,58)
21-59 21-59
4) Elementary = 20 (50) Elementary = 34 (46,6)
,3) High School = 12 (30) High School = 23 (31,5)
Professional = 3 (7,5) Professional = 6 (8,2)
College = 5 (12,5) College = 10 (13,7)
Until 1 = 2 (5) Until 1 = 2 (2,7)
,7) From 1 to 3 = 24 (60) From 1 to 3 = 46 (63)
,3) From 3 to 5 = 11 (27,5) From 3 to 5 = 21 (28,8)
From 5 to 10 = 3 (7,5) From 5 to 10 = 4 (5,5)
Married = 19 (47,5) Married = 33 (45,2)
Divorced = 6 (15) Divorced = 11 (15,1)
Single =13 (32,5) Single = 24 (32,9)









Table 2 Dependent variables means in the clinical and control groups and group comparisons
Variables Mean (SD); Range
Control group Clinical group Total t value; Cohen's d
BDI 8,33(8,69);0-37 16,70(10,17);1-49 12,92(10,35) 0-49 t = −3,73 (71); p < 0,001; d = 0,88
BAI 6,18(7,46) 0-25 19,73(12,69) 0-51 13,60(12,57) 0-51 t = −5,67 (64,68); p < 0,001; d = 1,41
WHOQOL 95,79(12,35) 59-127 82,20(15,33) 50-112 88,34(15,54) 50-127 t = 4,19 (70,97); p < 0,001; d = 0,99
WHOQOL1 27,06(3,74) 16-35 21,39(4,65) 11-33 23,95(5,10) 11-35 t = 5,67 (71); p < 0,001; d = 1,34
WHOQOL2 22,73(3,25) 14-30 19,97(4,37) 9-28 21,22(4,12) 9-30 t = 3,08 (70,32); p = 0,003; d = 0,73
WHOQOL3 11,61(2,16) 8-15 9,90(2,38) 4-14 10,67(2,43) 4-15 t = 3,17(71); p = 0,002; d = 0,75
WHOQOL4 27,33(4,37) 16-28 24,73(4,89) 11-33 25,90(4,81) 11-38 t = 2,38 (71); p = 0,02; d = 0,56
ALEXITHYMIA 53,21(9,49) 32-70 63,72(8,30) 50-89 58,97(10,25) 32-89 t = −5,05 (71); p < 0,001; d = 1,20
ALEX1 26,30(7,70) 11-42 32,28(7,82) 15-50 29,58(8,27) 11-50 t = −3,27 (71); p = 0,002; d = 0,78
ALEX2 16,09(4,57) 9-30 19,30(5,46) 7-33 17,85(5,29) 7-33 t = −2,69 (71); p = 0,009; d = 0,64
ALEX3 10,82(2,20) 7-17 12,15(2,52) 5-17 11,55(2,45) 5-17 t = −2,38 (71); p = 0,02; d = 0,56
SR 32,64(7,24) 14-46 28,88(5,43) 13-40 30,58(6,55) 13-46 t = 2,53 (71); p = 0,01; d = 0,60
INS 21,39(5,75) 9-29 16,33(6,14) 5-29 18,62(6,45) 5-29 t = 3,61 (71); p = 0,001; d = 0,86
SD = standard deviation; SR: Self-reflection; INS: Insight.
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1.41, showing that the groups presented very different
profiles regarding such variables.
Table 3 shows bivariate correlations between the
investigated variables, also including the sociodemographic
variables of the studies for the control and clinical groups.
Table 4 features associations among the following variables:
duration of disease (DD), duration of treatment (DT), pain
frequency in the last three months in days (PF) and an aver-
age grade attributed by the participants to their pain in the
last three months in a scale ranging from 0–10 (PG) with
the other variables. Association between pain frequency (in
days) in the last three months (PF), variables related to men-
tal health (depression and anxiety) and quality of life (total
and in the physical, psychological and environmental
domains) can be observed. The duration of disease (DD)
presented a positive association with the age of the
participants, while the variable average score attributed by
the participants to their pain in the last three months (PG)
was positively associated to anxiety levels and negatively to
insight capacity.
Considering the associations among variables described in
Table 4, ANCOVAs were performed with the purpose of in-
vestigating differences between the control and clinical
groups, controlling the co-variables effect. The co-variables
considered in each model were those that presented signifi-
cant associations with the dependent variable. Only the
variables total alexithymia and anxiety kept differences be-
tween the groups after control of the shared variance with
the other variables. So, the fact of belonging to the control
or to the clinical groups explains, respectively, 10% and 12%
of the variance of these variables.
Table 5 shows a multiple linear regression analysis
identifying predictors of quality of life for each groupand for the total sample. It also depicts those variables
predicting pain frequency (in days) in the last three
months (PF) for the clinical group. This analysis
evidences that depression, anxiety and alexithymia have
predictive power over quality of life in general and its
domains for the total, control and clinical groups.
Regarding specifically the clinical group, pain frequency
(PF) was predicted by the variables anxiety and ALEX1.
Finally, a binary logistic regression analysis (depicted
in Table 6) revealed that the variables that better distin-
guish the control and clinical groups are related to anx-
iety, the physical domain of quality of life (WHO1) and
concrete thinking style, based on reality, without imagin-
ation and fantasy (ALEX2). The model reached a satis-
factory level of correct classification of the cases, of 85%,
proving adequate to predict belonging to the respective
groups.
Discussion
The lack of correlation between alexithymia and
sociodemographic variables (age, income and educational
level) goes against discoveries of other studies [42,43]. This
might be due to the small size and relative homogeneity of
the sample in this study for both groups. However, regarding
the group of migraine sufferers, a lack of co-relation be-
tween alexithymia and sociodemographic variables was also
found in a Turkish sample, which points towards a possible
specificity in the grouping form of these variables in the mi-
graine sufferers group [3].
Migraine sufferers have shown higher levels of depres-
sion, anxiety and alexithymia, and lower levels of quality
of life, self-reflection and insight, compared to a group
of matched controls. The statistical significance of those
differences corroborates the empirical relevance of such
Table 3 Bivariate correlations between investigated variables
Variável Control group / Clinical groupa
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
1-BDI - 0,61** −0,76** −0,67** −0,77** −0,52** −0,64** 0,40* 0,40* 0,01 0,06 −0,23 −0,41** 0,19 −0,09 −0,08
2-BAI 0,62** - −0,49** −0,51** −0,45** −0,11 −0,43** 0,22 0,41** −0,23 −0,04 0,20 −0,54** 0,27 −0,15 −0,06
3-WHOQOL −0,72** −0,59** - 0,91** 0,91** 0,69** 0,86** −0,42** −0,23 −0,18 −0,30 0,265 0,34* −0,18 −0,11 0,02
4-WHOQOL1 −0,60** −0,68** 0,83** - 0,79** 0,53** 0,66** −0,41** −0,23 −0,19 −0,26 0,25 0,48** −0,29 −0,05 −0,02
5-WHOQOL2 −0,58** −0,31 0,87** 0,61** - 0,53** 0,69** −0,38* −0,26 −0,15 −0,11 0,31* 0,37* −0,09 −0,09 0,04
6-WHOQOL3 −0,50** −0,30 0,68** 0,48** 0,73** - 0,60** −0,28 −0,05 −0,23 −0,27 0,16 0,00 −0,08 −0,10 −0,07
7-WHOQOL4 −0,57** −0,44* 0,84** 0,56** 0,64** 0,41* - −0,36* −0,155 −0,14 −0,38* 0,20 0,18 −0,06 −0,06 0,12
8-ALEXITHYMIA 0,41* 0,41* −0,64** −0,53** −0,54** −0,36* −0,63** - 0,70** 0,46** 0,11 −0,20 −0,58** 0,04 0,23 0,08
9-ALEX-1 0,60** 0,47** −0,63** −0,56** −0,48** −0,38* −0,59** 0,80** - −0,24 −0,26 0,15 −0,64** 0,17 −0,01 0,12
10-ALEX2 −0,06 0,10 −0,22 −0,11 −0,28 −0,12 −0,21 0,61** 0,05 - 0,09 −0,49** −0,03 −0,13 0,25 −0,12
11-ALEX3 −0,21 −0,09 −0,09 −0,07 −0,05 0,04 −0,18 0,26 −0,17 0,36* - −0,07 0,13 −0,12 0,25 0,13
12-SR −0,31 −0,39 0,20 0,31 −0,04 −0,07 0,23 −0,34* −0,28 −0,20 −0,11 - −0,01 −0,11 0,00 0,21
13-INS −0,72** −0,56** 0,63** 0,57** 0,44* 0,52** 0,53** −0,58** −0,72** −0,07 0,17 0,30 - −0,20 0,11 0,00
14-Age −0,17 −0,09 0,20 −0,02 0,21 0,11 0,43* −0,21 −0,29 −0,03 0,19 0,20 0,09 - −0,15 0,07
15-Education −0,04 −0,09 0,05 0,01 0,01 −0,11 0,14 −0,05 −0,03 −0,01 −0,09 0,20 0,01 −0,08 - 0,41**
16-Outcome 0,04 0,14 −0,04 −0,07 −0,06 −0,19 0,13 −0,04 −0,15 0,19 −0,05 0,26 −0,03 0,02 0,65** -



















Table 4 Correlations between specific variables in the
clinical group
Variables DD DT PF PG
TL 0,21
PF −0,04 0,01
PG 0,08 0,02 0,20
BDI 0,18 0,24 0,45** 0,14
BAI 0,11 0,01 0,50** 0,37*
WHOQOL −0,20 −0,19 −0,45** 0,00
WHOQOL1 −0,16 −0,04 −0,51** −0,10
WHOQOL2 −0,11 −0,22 −0,43** 0,04
WHOQOL3 −0,13 −0,22 −0,21 0,23
WHOQOL4 −0,19 −0,22 −0,32* −0,01
ALEXITHYMIA 0,08 −0,08 0,11 0,26
ALEX1 0,20 −0,02 −0,07 0,30
ALEX2 −0,15 −0,17 0,16 0,08
ALEX3 −0,02 0,02 0,24 −0,24
SR −0,20 −0,13 −0,13 0,00
INS −0,22 0,13 −0,25 −0,32*
AGE 0,42** 0,11 0,07 0,08
EDUCATION −0,07 0,12 −0,09 −0,30
OUTCOME −0,06 −0,08 −0,01 −0,14
*p < 0,05; **p < 0,01.
Table 5 Linear regression models for quality of life and
pain frequency (in days) in the last three months (PF)
Sample Variable Predictors* B Beta Adjusted
Total WHO BDI −1,13 −0,76 0,70
Alex3 −1,35 −0,21
Alex2 −0,48 −0,16




WHO2 BDI −0,28 −0,72 0,57
Alex2 −0,15 −0,19
WHO3 BDI −0,13 −0,56 0,37
Alex2 −0,10 −0,21
WHO4 BDI −0,29 −0,63 0,50
Alex3 −0,61 −0,31
Control WHO BDI −1,04 −0,73 0,55
Alex2 −0,71 −0,26
BAI −0,27 −0,53 0,51
Alex1 −0,15 −0,31
WHO2 BDI −0,22 −0,59 0,39
Alex2 −0,22 −0,31
WHO3 Ins 0,20 0,52 0,25
WHO4 Alex1 −0,23 −0,41 0,49
Alex3 −0,68 −0,34
BDI −0,20 0,40
Clinical WHO BDI −1,12 −0,75 0,62
Alex3 −1,54 −0,25
WHO1 BDI −0,31 −0,67 0,44
WHO2 BDI −0,33 −0,77 0,58
WHO3 BDI −0,12 −0,52 0,25
WHO4 BDI −0,30 −0,62 0,50
Alex3 −0,67 −0,34
Clinical PF BAI 1,23 0,63 0,30
Alex1 −1,04 −0,33
* Predictors with a significance level ≤ 0.05 by stepwise estimation method.
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the diagnosed sufferers. Besides, showing high distinc-
tion for migraine comparing to the control group, the
relevance is stressed by the fact that the same variables
have not shown significant results, in terms of correl-
ation, interaction or distinction between groups, with
none of the sociodemographic data.
The scores for total alexithymia correlated negatively
with self-reflection and insight for the total sample and
the control group as well. However, in the clinical group
the total score for alexithymia only correlated negatively
with insight and not with self-reflection. This lack
of correlation between alexithymia and self-reflection
subscribes previous findings from a non-clinical sample
[32].
Discussion of the current data requires resorting to
conceptual matters. Alexithymia concerns incapacity or
difficulty to express emotions through words. Insight
refers to the individual capability of understanding one’s
own thoughts, feelings and behaviors. Self-reflection is
the individual practice of inspection and evaluation of
one’s own thoughts, feelings and behaviors. Sensibility in
perceiving internal states and the construct related to
one’s understanding of these states (insight) are certainly
associated with the capability of understanding and
expressing feelings [32]. Insight, in particular, predicts
several emotion and self-evaluation markers: individualswith higher insight have a better functioning on this
kind of capability, and insight predicts well-being
markers [44].
In the case of migraine sufferers of the present study,
there might be cognitive information processing regarding
internal states in some degree. However, since the correl-
ation direction expected and found in the control group
would be negative, it is possible that migraine disorder
associated with a type of chronic pain that “seizes” the pa-
tient and is hard to manage because of its unpredictability
makes sufferers effectively have a forced self-reflection prac-
tice. This self-reflection would be a perception of one’s
Table 6 Variables predicting pertinence to the clinical group
Binary logistic regression analysis
Predictors* B (e.p.) Wald (gl) Odds ratio Correct classification 85%
Total Group BAI 0,11 6,12 1,11
WHO1 −0,16 2,68 0,85
Alex2 0,17 4,96 1,18
* Predictors with a significance level ≤ 0.05 by stepwise estimation method.
Omnibus = 5,81(1), p = 0,02; Hosmer-Lemeshow = 16,85(8), p = 0,03.
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crisis and its possible internal or environmental triggers.
A reason to evaluate self-reflection and insight in clinical
groups is their potential application in contexts where atten-
tion and introspection abilities focusing on internal states
are able to predict the success of interventions [44]. In the
case of migraine, the abilities of this field might constitute
either resources or limiting features of important aspects of
pain and treatment management, such as observing crisis
triggers and evaluating medication effects.
Pain frequency in the last three months (PF) was sig-
nificantly correlated to depression, anxiety and total
quality of life and in the physical, psychological and so-
cial domains. This result stresses the strength of ap-
proximation of these variables in migraine, even if it is
not possible to draw casualty directions in this study be-
cause of its transversal character. The average grade
attributed by participants to their pain in the last three
months (PG) was negatively correlated to insight and
positively to anxiety. Perception and subjective evalu-
ation of pain might have been influenced in these
individuals by their loss of insight capability. In this way,
insight might be interpreted as a cognitive mediator be-
tween perception and expression of pain, with specific
effect, because of its interaction with alexithymia in the
case of migraines. Alexithymia is indeed reposted in lit-
erature as an increase factor for sensitivity to pain and
more somatic complaints [45].
There remains the question of whether elevated somatic
complaints, higher sensitivity and lower pain tolerance
in correlation to alexithymia could generate a model
or an operationalization of the mechanisms through
which migraine-related information is processed. Perhaps
alexithymia, as a phenomenon of having difficulty ex-
pressing feelings, is closer to an outcome function of a
process starting with self-reflection as a perception of
one’s internal states, continuing with insight as a quality
of cognitive data processing, supporting the individual’s
reasoning processes over causes and effects of their illness.
The logistic regression analysis indicated two alexithymia
dimensions (ALEX2 and ALEX3) and depression as
predictors of quality of life in the total sample. However,
comparing the clinical and control groups, each one
of those same alexithymia dimensions related to a
specific predictor. In the migraine sufferers group,quality of life (WHO) had as predictor, with negative
charge, the capability in expressing emotions and fan-
tasies (ALEX3), and in the control group, a concrete
thinking style, without imagination and fantasies
(ALEX2). This result is interesting because it relates
quality of life in migraine sufferers to the possibility
of expressing emotion and fantasy, reinforcing the im-
portance of developing spaces to express sickness and
treatment representations.
In the clinical group, pain frequency in the last three
months (PF) was predicted by the variables anxiety
and ability in identifying and describing feelings and
distinguishing them from bodily sensations (ALEX1).
This might happen because these variables are related to
one of the main triggers described in literature: emo-
tional stress.
In the binary logistic regression analysis, the Hosmer-
Lemeshow index suggested discrepancies between the
observed and predicted classifications, meaning that 15
percent of the cases were classified wrongly by the
model. That might have happened because the control
group is formed by individuals recruited in the primary
health care network, who frequently have other
disorders (hypertension, diabetes and asthma) which are
frequently associated with alexithymic traits [46-50].
However, this lack of “purity” in the control group along
with the significant difference of averages in all variables
(alexithymia, self-reflection, insight, depression, anxiety
and quality of life) reinforces the distinction between mi-
graine sufferers and non-sufferers and the importance of
the assessment of those variables in migraine patients.
On the other hand, by making an analysis inside the
clinical group, one can perceive a broad variability in
every one of the variables, which corroborates the idea
of intragroup heterogeneity among migraine sufferers.
The binary regression analysis of the division variable
of both clinical and control groups revealed that mi-
graine might characterize individuals with high anxiety,
low quality of life in the physical domain (WHO1), and
presence of a concrete thinking style, without imagin-
ation and fantasies (ALEX2). These results indicate the
importance of evaluating these features during the rou-
tine medical appointment and planning adequate
therapeutics aiming to decrease anxiety and developing
symbolization capacity in migraine sufferers.
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This study demonstrated that migraine sufferers presented
higher levels of depression, anxiety and alexithymia,
and lower levels of quality of life, self-reflection
and insight, comparing to control groups. However
seeming two completely different groups, there is a
high variability in all variables studied inside each group,
which shows an intragroup heterogeneity. Hence, the
results reinforce that while such variables present
themselves as relevant in migraine sufferers, health
professionals must evaluate them in their daily practice,
watching attentively every individual case.
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